NEW YORK — UK skin health startup Sequential Skin said on Monday that it has raised $1.65 million in an oversubscribed seed funding round.
The round was led by Metaplanet with participation from Scrum Ventures, SOSV, Genedant, and angel investor Ben Holmes. Sequential Skin said it has raised $2.15 million this year.
Sequential Skin offers an at-home test that includes an adhesive patch designed to collect a skin sample, which is returned to the company for next-generation sequencing and PCR analysis. The company said it uses the resulting data to generate a report detailing hydration, sensitivity response, firmness, sun protection, and antioxidant capacity of an individual's skin, as well as providing skin care recommendations.
The company, which also maintains operations in Singapore, said that it will use the new funding to expand its business-to-business efforts, as well as introduce a consumer-oriented test for the US market. Sequential Skin said the money will also be used to build its intellectual property portfolio and develop new technologies.
"We now have significant traction in assembling an extensive dataset on skin types from Asia, Europe, and the US — a great chance for us to discover novel biomarkers for skin conditions in different populations," Sequential Skin cofounder and CEO Oliver Worsley said in a statement.